Orleans, France

Marie-Noëlle Auguste


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marie-Noëlle Auguste

Introduction

Marie-Noëlle Auguste is a prominent inventor based in Orleans, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bradycardic medicinal products. With a total of 5 patents to his name, Auguste's work has had a notable impact on the medical community.

Latest Patents

Among his latest patents, Auguste has developed a β-crystalline form of ivabradine hydrochloride, which includes a detailed process for its preparation and pharmaceutical compositions containing it. This invention is characterized by its powder X-ray diffraction data and is aimed at creating medicinal products that are useful as bradycardics. Additionally, he has patented a γ-crystalline form of ivabradine hydrochloride, also characterized by its powder X-ray diffraction data, which serves similar medicinal purposes.

Career Highlights

Marie-Noëlle Auguste is currently associated with Les Laboratoires Servier, a well-respected company in the pharmaceutical industry. His work at this organization has allowed him to focus on innovative solutions that address critical health issues.

Collaborations

Throughout his career, Auguste has collaborated with notable colleagues, including Stéphane Horvath and Gérard Damien. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Marie-Noëlle Auguste's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of effective bradycardic treatments, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…